Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Unlike growth hormone peptides (which work through the pituitary) or GLP-1 peptides (which work through gut and brain receptors), BPC-157 works primarily through a different mechanism: it upregulates growth hormone receptors in tendon cells, stimulates angiogenesis (the formation of new blood vessels), and modulates nitric oxide signaling all of which contribute to accelerated tissue repair and reduced inflammation
Zinman B, et al
12 Is GLP-1 a type of insulin
For findings to be broadly applicable, the study population needs to reflect real-world patients in terms of age, gender, medical history, and dosing
Other approaches, such as oral GSH precursors or intravenous GSH, are promising, but they are invasive and not practical for home use
A major trend is the surge in metabolic disease therapies, with GLP-1 and tirzepatide treatments now generating nearly $45 billion combined
US$ 25.33
US$ 28.10
US$ 27.71
US$ 28.76
US$ 24.85
US$ 27.64
US$ 26.49
